Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

Alkermes Plc (NASDAQ:ALKS) reported strong financial results for the fourth quarter of 2024, surpassing earnings per share (EPS) and revenue forecasts. The company's EPS stood at $1.05, significantly ...